ACCO Brands (ACCO) is Trading Higher on Unusual Volume for February 10

Equities Staff |

ACCO Brands (ACCO) experienced unusually high volume on Feb. 10, as the stock gained 14.68% to a closing price of $6.72. The stock saw 993,873 shares trade hands over the course of the day on 6,009 trades. Given that the stock’s average daily volume over the last month has been 654,346 shares a day, this represents a pretty substantial spike over the norm.

ACCO Brands has a P/B ratio of 1.28. It also has a P/E ratio of 6.7. The stock has traded between $8.75 and $5.47 over the last 52-weeks, its 50-day SMA is now $6.76, and its 200-day SMA $7.44.

ACCO Brands Corp is a manufacturer & marketer of office, school & calendar products and select computer and electronic accessories. It sell its products to consumers & commercial end-users through resellers, including traditional office supply resellers.

Headquartered in Lake Zurich, IL, ACCO Brands has 5,240 employees and is currently under the leadership of CEO Boris Elisman.

For a complete fundamental analysis analysis of ACCO Brands, check out’s Stock Valuation Analysis report for ACCO. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…